Neurocrine(NBIX) - 2020 Q2 - Earnings Call Presentation

Neurocrine® Advancing Life-Changing Discoveries in Neuroscience Q2 2020 Corporate Presentation August 3, 2020 Nasdaq: NBIX neurocrine.com Safe Harbor Statement and Non-GAAP Financial Measures In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product ...